Literature DB >> 21832015

Bead-based multiplex genotyping of 58 cutaneous human papillomavirus types.

K M Michael1, O Forslund, O Bacevskij, T Waterboer, I G Bravo, M Pawlita, M Schmitt.   

Abstract

Cutaneous human papillomaviruses (HPVs) are a heterogeneous, nonmonophyletic assembly, comprising about 50 characterized types and at least 133 isolates putatively representing new types. Their natural history of infection and potential association with nonmelanoma skin cancer are not well understood. Several PCR systems have been developed that amplify a broad spectrum of cutaneous HPVs. However, amplicon genotyping by sequencing or reverse line blot assays are complex and not well suited for high-throughput analyses. We developed a novel multiplex cutaneous papillomavirus genotyping (McPG) assay for 38 defined and 20 putative cutaneous HPVs of the beta, gamma, mu, and nu genera. Viral DNA was amplified by the use of a modified single-tube nested "hanging-droplet" FAP PCR. The amplifiable papillomavirus (PV) spectrum was enlarged by the use of 9 outer and 13 inner primers. Biotinylated PCR products were hybridized to type-specific oligonucleotide probes coupled to fluorescence-labeled polystyrene beads and analyzed using Luminex technology. Analytical sensitivity was analyzed for 38 defined HPVs and was ≤100 genome copies for all types. Integrated β-globin primers allow for simultaneous DNA quality control. McPG is characterized by high reproducibility (κ= 0.84, 95% confidence interval = 0.79 to 0.88), good concordance with the original nested FAP PCR, followed by sequencing (70.2% complete or partial agreement) when 322 skin biopsy DNA samples were analyzed, and improved ability to detect multiple infections (on average 2.5 HPV types per HPV-positive sample compared to 1.7 HPV types with nested FAP-PCR). In conclusion, McPG is a powerful tool for genotyping multiple cutaneous HPVs in a high-throughput format and is thus suitable for large-scale epidemiological studies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21832015      PMCID: PMC3187343          DOI: 10.1128/JCM.01173-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  38 in total

1.  Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients.

Authors:  R J Berkhout; J N Bouwes Bavinck; J ter Schegget
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Human papillomavirus type 17 transcripts expressed in skin carcinoma tissue of a patient with epidermodysplasia verruciformis.

Authors:  M Yutsudo; A Hakura
Journal:  Int J Cancer       Date:  1987-05-15       Impact factor: 7.396

Review 3.  Papillomaviruses and cancer: from basic studies to clinical application.

Authors:  Harald zur Hausen
Journal:  Nat Rev Cancer       Date:  2002-05       Impact factor: 60.716

4.  Improved detection of cutaneous human papillomavirus DNA by single tube nested 'hanging droplet' PCR.

Authors:  Ola Forslund; Hoang Ly; Geoff Higgins
Journal:  J Virol Methods       Date:  2003-06-30       Impact factor: 2.014

5.  Detection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers.

Authors:  L M Tieben; J ter Schegget; R P Minnaar; J N Bouwes Bavinck; R J Berkhout; B J Vermeer; M F Jebbink; H L Smits
Journal:  J Virol Methods       Date:  1993-05       Impact factor: 2.014

6.  Abundance of multiple high-risk human papillomavirus (HPV) infections found in cervical cells analyzed by use of an ultrasensitive HPV genotyping assay.

Authors:  Markus Schmitt; Bolormaa Dondog; Tim Waterboer; Michael Pawlita; Massimo Tommasino; Tarik Gheit
Journal:  J Clin Microbiol       Date:  2009-10-28       Impact factor: 5.948

Review 7.  Classification of papillomaviruses.

Authors:  Ethel-Michele de Villiers; Claude Fauquet; Thomas R Broker; Hans-Ulrich Bernard; Harald zur Hausen
Journal:  Virology       Date:  2004-06-20       Impact factor: 3.616

8.  A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions.

Authors:  M Dürst; L Gissmann; H Ikenberg; H zur Hausen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

9.  General acquisition of human papillomavirus infections of skin occurs in early infancy.

Authors:  Annika Antonsson; Silvana Karanfilovska; Pelle G Lindqvist; Bengt Göran Hansson
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

Review 10.  Chapter 8: Human papillomavirus and skin cancer.

Authors:  Herbert Pfister
Journal:  J Natl Cancer Inst Monogr       Date:  2003
View more
  3 in total

1.  Evaluation of a novel multiplex human papillomavirus (HPV) genotyping assay for HPV types in skin warts.

Authors:  Markus Schmitt; Maurits N C de Koning; Just A H Eekhof; Wim G V Quint; Michael Pawlita
Journal:  J Clin Microbiol       Date:  2011-08-03       Impact factor: 5.948

Review 2.  Human papillomavirus in head and neck cancer.

Authors:  Anna Rosa Garbuglia
Journal:  Cancers (Basel)       Date:  2014-08-18       Impact factor: 6.639

3.  Intralesional EBV-DNA load as marker of prognosis for nasopharyngeal cancer.

Authors:  Johan S Nilsson; Ola Forslund; Fredrik C Andersson; Malin Lindstedt; Lennart Greiff
Journal:  Sci Rep       Date:  2019-10-28       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.